Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-004310

Options or other derivatives

  • President and CEO acquired 344,700 shares (grant or award)
  • President and CEO returned 517,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Kinney Gene G. · President and CEO

Table II: Derivative

12 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-12 Returned to the company : show line 1 in the form Employee Stock Option (Right to Buy) −65,000 $27.81 2025-03-11 65,000 0 D
2021-02-12 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +59,090 $22.85 2025-03-11 59,090 59,090 D
2021-02-12 Returned to the company : show line 3 in the form Employee Stock Option (Right to Buy) −65,000 $34.61 2026-02-24 65,000 0 D
2021-02-12 Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) +40,625 $22.85 2026-02-24 40,625 40,625 D
2021-02-12 Returned to the company : show line 5 in the form Employee Stock Option (Right to Buy) −50,000 $52.21 2026-09-01 50,000 0 D
2021-02-12 Grant or award : show line 6 in the form Employee Stock Option (Right to Buy) +25,125 $22.85 2026-09-01 25,125 25,125 D
2021-02-12 Returned to the company : show line 7 in the form Employee Stock Option (Right to Buy) −30,000 $45.13 2026-11-02 30,000 0 D
2021-02-12 Grant or award : show line 8 in the form Employee Stock Option (Right to Buy) +16,759 $22.85 2026-11-02 16,759 16,759 D
Loading xslF345X03/doc1.xml…